Further analysis using ROC curves showed that the AUC of CD45+EpCAM+ cell ratio in PBMCs of patients with lung cancer was 0.845, which was slightly higher than that of serum CEA level changes (0.732). This evidence concerns the gene EPCAM and lung carcinoma.